The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients

The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients - The study about the efficacy of the 23-valent pneumococcal polysaccharide vaccine among dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032511

Enrollment

1000

Registered

2018-05-09

Start date

2016-03-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic renal failure on dialysis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: consecutive patients undergoing dialysis at any one of the study centers between January 1 and December 31, 2010

Exclusion criteria

Exclusion criteria: No regular visits

Design outcomes

Primary

Measure	Time frame
First admission, or deaths due to all-cause pneumonia or cardiac events.	—

Countries

Japan

Contacts

Public ContactHiroaki Ihara

Juntendo University, School of Medicine Respiratory Medicine

h-ihara@juntendo.ac.jp03-3813-3111

Outcome results